The aim of this study is to assess the feasibility and the validity of the 2-minute walk test (2MWT) and the 10-meter walk test (10MeWT) compared to the 6-minute walk test (6MWT) for subjects with onco-hematological disease.
Cancer and its treatments have an impact on the body as a whole. The analysis of the subject's physical capacity is essential to know the basic level of the subject pre-treatment, to evaluate progress following rehabilitation, to set goals to prevent decline in physical capacity or to evaluate changes in physical capacity at different stages of survival. The 6-minute walk test (6MWT) is frequently used in the clinic to assess the physical capacity of the subject in oncology. A variant of the 6MWT exists and has been little studied in an oncological context: the 2-minute walk test (2MWT). The 2MWT is performed in the same way as the 6MWT: the same instructions and the same test procedure. It offers the advantage of being less tiring for the test subjects and saves clinicians time. The 2MWT has been validated in the past for people with COPD or after cardiac surgery. To our knowledge, it has not been validated for cancer patients. The 10-meter walk test (10MeWT) is frequently used in practice to assess patients' functional capacity. It would be another way to assess the walking ability with a short test. However, the relationship between the 2MWT, 6MWT and 10MeWT in an oncological context remain unclear.
Study Type
OBSERVATIONAL
Enrollment
56
The subject walks as far as possible for 6 minutes along a 30m long corridor.
The subject walks as far as possible for 2 minutes along a 30m long corridor.
The natural and fast walking speeds of the subject are measured over 10m. This speed is measured by the examiner as well as by the subject (self-tested version).
Geneva University Hospitals
Geneva, Switzerland
Primary endpoint: feasibility of the 2MWT and the 10MeWT
The feasibility of the different tests will be assessed in an oncological setting.
Time frame: through study completion, an average of 1 year
Primary endpoint: criterion validity with the 6MWT
Criterion validity will be assessed by calculating the strength of the correlation between the 2MWT/10MeWT and the 6MWT.
Time frame: through study completion, an average of 1 year
Secondary endpoint: convergent construct validity
Convergent construct validity will be evaluated by calculating the strength of the correlation between the 2MWT and the 10m walk test at comfortable/fast speed
Time frame: through study completion, an average of 1 year
Secondary endpoint: criterion validity between 10m walk test and 10m walk test self-tested
Criterion validity will be assessed by calculating the strength of the correlation between the 10m walk test self-tested and the 10m walk test timed by the examiner.
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The time held in unipodal equilibrium is measured by the examiner.